531752 — Biogen Pharmachem Industries Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹580.82m
- IN₹577.59m
Annual cashflow statement for Biogen Pharmachem Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.17 | -16 | -0.086 | 4.55 | 19.3 |
| Depreciation | |||||
| Changes in Working Capital | -11 | 55.5 | 14.1 | 12.5 | 0.138 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12.1 | 39.5 | 14 | 17 | 19.4 |
| Other Investing Cash Flow Items | 15.4 | -36.4 | -13.2 | -16.6 | -20.6 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 15.4 | -36.4 | -13.2 | -16.6 | -20.6 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.24 | -3.06 | 0 | 0 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.003 | 0.041 | 0.757 | 0.455 | -1.12 |